NCT07728058 Dry Cord Care Versus Alcohol Cord Care in Healthy Newborns
| NCT ID | NCT07728058 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Chang Gung Memorial Hospital |
| Condition | Umbilical Cord Infection |
| Study Type | INTERVENTIONAL |
| Enrollment | 210 participants |
| Start Date | 2026-07-07 |
| Primary Completion | 2028-04 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 210 participants in total. It began in 2026-07-07 with a primary completion date of 2028-04.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Umbilical cord care is an essential component of newborn care, but the optimal method remains controversial. This randomized controlled trial aims to compare routine alcohol cord care with natural dry cord care in healthy newborns. A total of 210 mother-infant dyads will be randomly assigned to either routine alcohol cord care or natural dry cord care. The primary outcome is the incidence of umbilical cord infection. Secondary outcomes include umbilical cord separation time, bacterial colonization, and healthcare resource utilization for umbilical cord care. The findings of this study will provide evidence to support optimal umbilical cord care practices for healthy newborns.
Eligibility Criteria
Inclusion Criteria: * Healthy neonates with a gestational age of 35 weeks or greater. * Birth weight of 2,300 g or greater. * Normal umbilical cord appearance at birth, with no evidence of trauma, infection, or congenital abnormalities of the umbilical cord. Exclusion Criteria: * Neonates born to mothers with intrapartum fever (≥38°C), clinical chorioamnionitis, or rupture of membranes for more than 18 hours * Meconium-stained amniotic fluid. * Neonates admitted directly to the Newborn Care Center (NBC) or Pediatric Intensive Care Unit (PICU) after birth. * Neonates from multiple gestations.
Contact & Investigator
TZU-MIN CHEN, RN
PRINCIPAL INVESTIGATOR
Chang Gung Memorial Hospital
Frequently Asked Questions
Who can join the NCT07728058 clinical trial?
This trial is open to participants of all sexes, aged 0 Days or older, up to 28 Days, studying Umbilical Cord Infection. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07728058 currently recruiting?
Yes, NCT07728058 is actively recruiting participants. Contact the research team at zimin0915@cgmh.org.tw for enrollment information.
Where is the NCT07728058 trial being conducted?
This trial is being conducted at New Taipei City, Taiwan.
Who is sponsoring the NCT07728058 clinical trial?
NCT07728058 is sponsored by Chang Gung Memorial Hospital. The principal investigator is TZU-MIN CHEN, RN at Chang Gung Memorial Hospital. The trial plans to enroll 210 participants.